Alpha blockers and ejaculatory function: A state of the art review

Current Sexual Health Reports

Volumn 4, Issue 3, 2007, Pages 141-144

  Miller Jr , Javier ^a   Carson, Culley C ^b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT;

DRUG EFFICACY; EJACULATION DISORDER; HUMAN; PREMATURE EJACULATION; PROSTATE HYPERTROPHY; REVIEW; SEXUAL DYSFUNCTION; TREATMENT OUTCOME; URINARY TRACT DISEASE;

EID: 34548776609     PISSN: 15483584     EISSN: 15483592     Source Type: Journal    
DOI: 10.1007/s11930-007-0016-z     Document Type: Review

References (29)

1. Miner M, Rosenberg MT, Perelman MA: Treatment of lower urinary tract symptoms in benign prostatic hyperplasia and its impact on sexual function. Clin Ther 2006, 28:13-25.
2. Palea S, Barras M: Comparison of the relaxant effects of alfuzosin, phentolamine and sildenafil on rabbit isolated corpus cavernosum. BJU Int 2003, 91:873-877.
3. Palea S, Barras M, Deplanne V, et al.: Antagonist effects of alfuzosin on concentration-response curves to phenylephrine and noradrenaline in human prostatic adenoma [abstract]. Neurourol Urodyn 2000, 19:431.
4. •• Hisasue S, Furuya R, Itoh N, et al.: Ejaculatory disorder caused by alpha-1 adrenoreceptor antagonists is not retrograde ejaculation but a loss of seminal emission. Int J Urol 2006, 13:1311-1316. This is a well-designed study supporting that the ejaculatory dysfunction caused by tamsulosin is due to an induced seminal emission disorder, not retrograde ejaculation.
5. Arai Y, Aoki Y, Okubo K, et al.: Impact of interventional therapy for benign prostatic hyperplasia on quality of life and sexual function: a prospective study. J Urol 2000, 164:1206-1211.
6. Braun M, Wassmer G, Klotz T, et al.: Epidemiology of erectile dysfunction: results of the 'Cologne Male Survey'. Int J Impot Res 2000, 12:305-311.
7. Rosen RC, Seidman SN, Menza MA, et al.: Quality of life, mood, and sexual function: a path analytic model of treatment effects in men with erectile dysfunction and depressive symptoms. Int J Impot Res 2004, 16:334-340.
8. • McVary KT: Sexual Function and alpha-blockers. Rev Urol 2005, 7(Suppl 8):S3-S11. This review outlines theories linking BPH and LUTS with ED.
9. Rosen R, Altwein J, Boyle P, et al.: Lower urinary tract symptoms and male sexual dysfunction: the Multinational Survey of the Aging Male (MSAM-7). Eur Urol 2003, 44:637-649.
10. Bloch W, Klotz T, Loch C, et al.: Distribution of nitric oxide synthase implies a regulation of circulation, smooth muscle tone, and secretory function in the human prostate by nitric oxide. Prostate 1997, 33:1-8.
11. Klotz T, Bloch W, Loch C, et al.: Pattern of distribution of constitutive isoforms of NO synthase in the normal prostate and obstructive prostatic hyperplasia. Urology 1997, 36:318-322.
12. McVary KT, Razzaq A, Lee C, et al.: Growth of the rat prostate gland is facilitated by the autonomic nervous system. Biol Reprod 1994, 51:99-107.
13. Golomb E, Rosenzweig N, Ellam R, et al.: Spontaneous hyperplasia of the ventral lobe of the prostate in aging genetically hypertensive rats. J Androl 2000, 21:58-64.
14. Tong YC, Hung YC, Lin SN, et al.: The norepinephrine tissue concentration and neuropeptide Y immunoreactivity in genitourinary organs of the spontaneously hypertensive rat. J Auton Nerv Syst 1996, 56:215-218.
15. Hale TM, Okabe H, Bushfield TL, et al.: Recovery of erectile function after brief aggressive antihypertensive therapy. J Urol 2002, 168:348-354.
16. Chang S, Hypolite JA, Zderic SA, et al.: Enhanced force generation by corpus cavernosum smooth muscle in rabbits with partial bladder outlet obstruction. J Urol 2002, 167:2636-2644.
17. Tarcan T, Azadzoi KM, Siroky MB, et al.: Age related erectile and voiding dysfunction: the role of arterial insufficiency. Br J Urol 1998, 82(Suppl 1):26-33.
18. Lukacs B, Leplege A, Thibault P, et al.: Prospective study of men with clinical benign prostatic hyperplasia treated with alfuzosin by general practitioners: 1 year results. Urology 1996, 48:731-740.
19. Van Moorselaar P, Hartung R, Emberton M, et al.: Alfuzosin 10 mg once daily improves sexual function in men with lower urinary tract symptoms and concomitant sexual dysfunction. BJU Int 2005, 95:603-608.
20. Nickel JC, Elhilali M, Emberton M, et al.: The beneficial effect of alfuzosin 10 mg once daily in 'real-life' practice on lower urinary tract symptoms (LUTS), quality of life and sexual dysfunction in men with LUTS and painful ejaculation. BJU Int 2006, 97:1242-1246.
21. Kirby RS, O'leary MP, Carson CC: Efficacy of extended-release doxazosin and doxazosin standard in patients with concomitant benign prostatic hyperplasia and sexual dysfunction. BJU Int 2005, 95:103-109.
22. Yassin A, Diede HE: Combination therapy. Alpha 1-adrenoreceptor blockade and tadalafil in BPH population. Int J Impot Res 2003, 15:S181-S182.
23. AUA Practice Guidelines Committee: AUA guideline on management of benign prostatic hyperplasia (2003). Chapter 1: Diagnosis and treatment recommendations. J Urol 2003, 170:530-547.
24. Hellstrom WJ, Sikka SC: Effects of acute treatment with tamsulosin versus alfuzosin on ejaculatory function in normal volunteers. J Urol 2006, 176:1529-1533.
25. Giuliano F: Impact of medical treatments for benign prostatic hyperplasia on sexual function. BJU Int 2006, 97(Suppl 2):34-38.
26. Giuliano F, Bernabe J, Droupy S, et al.: A comparison of the effects of tamsulosin and alfuzosin on neurally evoked increases in bladder neck and seminal vesicle pressure in rats. BJU Int 2004, 93:605-608.
27. •• Basar MM, Yilmaz E, Ferhat M, et al.: Terazosin in the treatment of premature ejaculation: a short-term follow-up. Int Urol Nephrol 2005, 37:773-777. This is a well-designed study outlining the efficacy of terazosin when treating patients with premature ejaculation.
28. Master VA, Turek PJ: Ejaculatory physiology and dysfunction. Urol Clin North Am 2001, 28:363-375.
29. Abdel-Hamid IA: Can smooth muscle represent a useful target for the treatment of rapid ejaculation? Drug Discov Today 2005, 10:1459-1466.